Ferric Citrate Tablet, Film Coated
NDC Package 0480-2996-97
Package Information
Ferric Citrate tablets is ferric citrate is used to lower high blood phosphate levels in people who are on dialysis due to severe kidney disease. This formulation utilizes a tablet, film coated delivery system. Marketed by Teva Pharmaceuticals, Inc., this product is identified by NDC 0480-2996 and is authorized under FDA application ANDA212563.
Identification & Billing
- RxCUI: 1594680 - ferric citrate (as iron) 210 MG Oral Tablet
- RxCUI: 1594680 - ferric citrate 1000 MG Oral Tablet
- RxCUI: 1594680 - ferric citrate 1 GM (iron 210 MG) Oral Tablet
- RxCUI: 1594680 - ferric citrate 1 GM Oral Tablet
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0480 - Teva Pharmaceuticals, Inc.
- 0480-2996 - Ferric Citrate
- 0480-2996-97 - 200 TABLET, FILM COATED in 1 BOTTLE
- 0480-2996 - Ferric Citrate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0480-2996-97 identifies a specific commercial package of 200 tablet, film coated in 1 bottle of Ferric Citrate, a human prescription drug labeled by Teva Pharmaceuticals, Inc.. This tablet, film coated is formulated for oral use and contains ferric citrate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Teva Pharmaceuticals, Inc. on March 11, 2026. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Ferric citrate is used to lower high blood phosphate levels in people who are on dialysis due to severe kidney disease. Dialysis removes some phosphate from your blood, but it is difficult to remove enough to keep your phosphate levels balanced. Decreasing blood phosphate levels can help keep your bones strong, prevent unsafe buildup of minerals in your body, and may decrease the risk of heart disease and strokes that can result from high phosphate levels. This medication works by binding to phosphate in the foods you eat. The phosphate then passes out of your body in your stool. Ferric citrate is a form of iron. This medication is also used to treat low blood levels of iron (anemia) in people with long-term kidney disease who are not on dialysis. Iron is an important mineral that your body needs to produce red blood cells and keep you in good health.
How is this Teva Pharmaceuticals, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00480299697. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 200 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.